|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1565 SEK | +2.29% |
|
-11.58% | -77.48% |
| 04-23 | Spermosens AB Appoints Tore Duvold as CEO, Effective May 1, 2024 | CI |
| 02-09 | Spermosens AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Spermosens AB reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was SEK 2.23 million compared to SEK 4.6 million a year ago. Revenue was SEK 2.25 million compared to SEK 5.15 million a year ago.
Net loss was SEK 3.15 million compared to SEK 1.37 million a year ago. Basic loss per share from continuing operations was SEK 0.26 compared to SEK 0.13 a year ago.
SPERMOSENS AB 
